Your browser doesn't support javascript.
loading
EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer.
Birkman, Eva-Maria; Avoranta, Tuulia; Ålgars, Annika; Korkeila, Eija; Lintunen, Minnamaija; Lahtinen, Laura; Kuopio, Teijo; Ristamäki, Raija; Carpén, Olli; Sundström, Jari.
Afiliación
  • Birkman EM; Department of Pathology, University of Turku, 20520 Turku, Finland; Department of Pathology, Turku University Hospital, 20520 Turku, Finland. Electronic address: emabir@utu.fi.
  • Avoranta T; Department of Pathology, University of Turku, 20520 Turku, Finland; Department of Oncology, Turku University Hospital, 20521 Turku, Finland.
  • Ålgars A; Department of Oncology, Turku University Hospital, 20521 Turku, Finland; MediCity Research Laboratory, University of Turku, 20520 Turku, Finland.
  • Korkeila E; Department of Oncology, Turku University Hospital, 20521 Turku, Finland.
  • Lintunen M; Department of Pathology, Turku University Hospital, 20520 Turku, Finland.
  • Lahtinen L; Department of Pathology, Central Finland Central Hospital, 40620 Jyväskylä, Finland.
  • Kuopio T; Department of Pathology, Central Finland Central Hospital, 40620 Jyväskylä, Finland; Department of Biological and Environmental Science, University of Jyväskylä, 40014 Jyväskylä, Finland.
  • Ristamäki R; Department of Oncology, Turku University Hospital, 20521 Turku, Finland.
  • Carpén O; Pathology, Research Programs Unit and HUSLAB, University of Helsinki and Helsinki University Hospital, 00014 Helsinki, Finland; Auria Biobank, University of Turku and Turku University Hospital, 20521 Turku, Finland.
  • Sundström J; Department of Pathology, University of Turku, 20520 Turku, Finland; Department of Pathology, Turku University Hospital, 20520 Turku, Finland.
Hum Pathol ; 82: 163-171, 2018 12.
Article en En | MEDLINE | ID: mdl-30096327

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Dosificación de Gen / Cetuximab / Antineoplásicos Inmunológicos / Panitumumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Dosificación de Gen / Cetuximab / Antineoplásicos Inmunológicos / Panitumumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article